| Year |
Citation |
Score |
| 2020 |
Banerjee R, Komarow L, Virk A, Rajapakse N, Schuetz AN, Dylla B, Earley M, Lok J, Kohner P, Ihde S, Cole N, Hines L, Reed K, Garner OB, Chandrasekaran S, et al. Randomized trial evaluating clinical impact of RAPid IDentification and Susceptibility testing for Gram Negative bacteremia (RAPIDS-GN). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32374822 DOI: 10.1093/Cid/Ciaa528 |
0.355 |
|
| 2019 |
Banerjee R, Banerjee R, Komarow L, Virk A, Rajapakse NS, Schuetz A, Dylla B, Earley M, Lok J, Kohner P, Ihde S, Cole N, Hines L, Reed K, Garner O, et al. 640. Randomized Clinical Trial Evaluating Clinical Impact of RAPid IDentification and Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia (RAPIDS-GN) Open Forum Infectious Diseases. 6: S296-S297. DOI: 10.1093/Ofid/Ofz360.708 |
0.345 |
|
| 2018 |
Yang S, Lok JJ. SENSITIVITY ANALYSIS FOR UNMEASURED CONFOUNDING IN COARSE STRUCTURAL NESTED MEAN MODELS. Statistica Sinica. 28: 1703-1723. PMID 30853756 DOI: 10.5705/ss.202016.0133 |
0.395 |
|
| 2017 |
Huvane J, Komarow L, Hill C, Tran TT, Pereira C, Rosenkranz SL, Finnemeyer M, Earley M, Jiang HJ, Wang R, Lok J, Evans SR. Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 64: S18-S23. PMID 28350899 DOI: 10.1093/Cid/Ciw827 |
0.333 |
|
| 2017 |
Lok JJ, Yang S, Sharkey B, Hughes MD. Estimation of the cumulative incidence function under multiple dependent and independent censoring mechanisms. Lifetime Data Analysis. PMID 28238045 DOI: 10.1007/s10985-017-9393-4 |
0.319 |
|
| 2016 |
Lok JJ, Hughes MD. Evaluating predictors of competing risk outcomes when censoring depends on time-dependent covariates, with application to safety and efficacy of HIV treatment. Statistics in Medicine. PMID 26763556 DOI: 10.1002/sim.6852 |
0.347 |
|
| 2015 |
Schnitzer ME, Lok JJ, Gruber S. Variable Selection for Confounder Control, Flexible Modeling and Collaborative Targeted Minimum Loss-Based Estimation in Causal Inference. The International Journal of Biostatistics. PMID 26226129 DOI: 10.1515/Ijb-2015-0017 |
0.313 |
|
| 2015 |
Schnitzer ME, Lok JJ, Bosch RJ. Double robust and efficient estimation of a prognostic model for events in the presence of dependent censoring. Biostatistics (Oxford, England). PMID 26224070 DOI: 10.1093/biostatistics/kxv028 |
0.473 |
|
| 2012 |
Lok JJ, DeGruttola V. Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients. Biometrics. 68: 745-54. PMID 22352840 DOI: 10.1111/J.1541-0420.2011.01738.X |
0.31 |
|
| 2011 |
Ribaudo HJ, Benson CA, Zheng Y, Koletar SL, Collier AC, Lok JJ, Smurzynski M, Bosch RJ, Bastow B, Schouten JT. No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 929-40. PMID 21427402 DOI: 10.1093/Cid/Ciq244 |
0.348 |
|
| 2004 |
Lok J, Gill R, Vaart Avd, Robins J. Estimating the causal effect of a time-varying treatment on time-to-event using structural nested failure time models Statistica Neerlandica. 58: 271-295. DOI: 10.1111/J.1467-9574.2004.00123.X |
0.408 |
|
| 1998 |
Hettiarachchi RJK, Lok J, Prins MH, Büller HR, Prandoni P. Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis. Cancer. 83: 180-185. PMID 9655309 DOI: 10.1002/(Sici)1097-0142(19980701)83:1<180::Aid-Cncr24>3.0.Co;2-S |
0.347 |
|
| Show low-probability matches. |